These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16829932)

  • 1. The ups and downs of Abeta.
    Selkoe DJ
    Nat Med; 2006 Jul; 12(7):758-9; discussion 759. PubMed ID: 16829932
    [No Abstract]   [Full Text] [Related]  

  • 2. beta-amyloid: friend or foe.
    Campbell A
    Med Hypotheses; 2001 Mar; 56(3):388-91. PubMed ID: 11359367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abeta star: a light onto synaptic dysfunction?
    Kim SH; Tang YP; Sisodia SS
    Nat Med; 2006 Jul; 12(7):760-1; discussion 761. PubMed ID: 16829934
    [No Abstract]   [Full Text] [Related]  

  • 4. The APP family of proteins: similarities and differences.
    Walsh DM; Minogue AM; Sala Frigerio C; Fadeeva JV; Wasco W; Selkoe DJ
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):416-20. PubMed ID: 17371289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A highly insoluble state of Abeta similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice.
    Philipson O; Hammarström P; Nilsson KP; Portelius E; Olofsson T; Ingelsson M; Hyman BT; Blennow K; Lannfelt L; Kalimo H; Nilsson LN
    Neurobiol Aging; 2009 Sep; 30(9):1393-405. PubMed ID: 18192084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular amyloid-beta in Alzheimer's disease.
    LaFerla FM; Green KN; Oddo S
    Nat Rev Neurosci; 2007 Jul; 8(7):499-509. PubMed ID: 17551515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologic origins of age-related beta-amyloid deposition.
    Beach TG
    Neurodegener Dis; 2008; 5(3-4):143-5. PubMed ID: 18322373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble beta-amyloid leads to mitochondrial defects in amyloid precursor protein and tau transgenic mice.
    Eckert A; Hauptmann S; Scherping I; Rhein V; Müller-Spahn F; Götz J; Müller WE
    Neurodegener Dis; 2008; 5(3-4):157-9. PubMed ID: 18322377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Abeta production leads to intracellular accumulation of Abeta in flotillin-1-positive endosomes.
    Rajendran L; Knobloch M; Geiger KD; Dienel S; Nitsch R; Simons K; Konietzko U
    Neurodegener Dis; 2007; 4(2-3):164-70. PubMed ID: 17596711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward a remembrance of things past: deciphering Alzheimer disease.
    Selkoe DJ
    Harvey Lect; 2003-2004; 99():23-45. PubMed ID: 15984550
    [No Abstract]   [Full Text] [Related]  

  • 11. Alzheimer's disease: a dissection of its etiology.
    Jay G
    J Neurovirol; 1997 May; 3 Suppl 1():S41-2. PubMed ID: 9179790
    [No Abstract]   [Full Text] [Related]  

  • 12. A transgenic triple scores a home run.
    Cole G
    Nat Med; 2006 Jul; 12(7):762-3; discussion 763. PubMed ID: 16829936
    [No Abstract]   [Full Text] [Related]  

  • 13. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition.
    Flood DG; Lin YG; Lang DM; Trusko SP; Hirsch JD; Savage MJ; Scott RW; Howland DS
    Neurobiol Aging; 2009 Jul; 30(7):1078-90. PubMed ID: 18053619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid-beta precursor protein mediates neuronal toxicity of amyloid beta through Go protein activation.
    Sola Vigo F; Kedikian G; Heredia L; Heredia F; Añel AD; Rosa AL; Lorenzo A
    Neurobiol Aging; 2009 Sep; 30(9):1379-92. PubMed ID: 18187234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype.
    Piccini A; Zanusso G; Borghi R; Noviello C; Monaco S; Russo R; Damonte G; Armirotti A; Gelati M; Giordano R; Zambenedetti P; Russo C; Ghetti B; Tabaton M
    Arch Neurol; 2007 May; 64(5):738-45. PubMed ID: 17502474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway.
    Masters CL; Beyreuther K
    Brain; 2006 Nov; 129(Pt 11):2823-39. PubMed ID: 17012295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced brain volumes in mice expressing APP-Austrian mutation but not in mice expressing APP-Swedish-Austrian mutations.
    Van Broeck B; Vanhoutte G; Cuijt I; Pereson S; Joris G; Timmermans JP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
    Neurosci Lett; 2008 Dec; 447(2-3):143-7. PubMed ID: 18840503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches.
    Van Broeck B; Van Broeckhoven C; Kumar-Singh S
    Neurodegener Dis; 2007; 4(5):349-65. PubMed ID: 17622778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia increases Abeta generation by altering beta- and gamma-cleavage of APP.
    Li L; Zhang X; Yang D; Luo G; Chen S; Le W
    Neurobiol Aging; 2009 Jul; 30(7):1091-8. PubMed ID: 18063223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.